RATIONAL DRUG DESIGN OF POTENT V600E-BRAF KINASE INHIBITORS THROUGH MOLECULAR DOCKING SIMULATION
B-RAF is a one of the RAF protein kinase group that contribute to the development of different types of cancer. V600E-BRAF protein has lot potential for scientific investigation as the therapeutic target owing to its participation in melanoma cancer and is the molecular target of many anticancer co...
Saved in:
Main Authors: | Bello Abdullahi Umar, Adamu Uzairu, Gideion Adamu Shallangwa, Sani Uba |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade Federal de Viçosa (UFV)
2019-12-01
|
Series: | The Journal of Engineering and Exact Sciences |
Subjects: | |
Online Access: | https://periodicos.ufv.br/jcec/article/view/8460 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Frecuencia de la inmunosupresión de BRAF V600E en ameloblastomas: Un análisis multi-insituticional de 86 casos en América Latina
by: Lauren Frenzel Schuch, et al.
Published: (2024-12-01) -
Frequent mutation of K-RAS in addition to BRAF V600E in Ameloblastoma – An immunohistochemical study
by: Aishwariya Mohanty, et al.
Published: (2024-06-01) -
Systemic therapy of skin metastatic melanoma with BRAF gene mutation
by: Yu. S. Shakh-Paronyants, et al.
Published: (2023-03-01) -
BRAF inhibitor monotherapy in BRAFV600E-mutated pediatric low-grade glioma: a single center’s experience
by: S. S. McThenia, et al.
Published: (2025-01-01) -
Primary mucoepidermoid carcinoma of the thyroid with concomitant MAML2 gene rearrangement and BRAF V600E mutation – A case report
by: Frederica Loghides, et al.
Published: (2024-03-01)